Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.
Medicine Genetics Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
J Med Genet. 2024 Jul 19;61(8):727-733. doi: 10.1136/jmg-2024-109878.
This document addresses the clinical application of next-generation sequencing (NGS) technologies for prenatal genetic diagnosis and aims to establish clinical practice recommendations in Spain to ensure uniformity in implementing these technologies into prenatal care.
A joint committee of expert obstetricians and geneticists was created to review the existing literature on fetal NGS for genetic diagnosis and to make recommendations for Spanish healthcare professionals.
This guideline summarises technical aspects of NGS technologies, clinical indications in prenatal setting, considerations regarding findings to be reported, genetic counselling considerations as well as data storage and protection policies.
This document provides updated recommendations for the use of NGS diagnostic tests in prenatal diagnosis. These recommendations should be periodically reviewed as our knowledge of the clinical utility of NGS technologies, applied during pregnancy, may advance.
本文针对产前基因诊断中下一代测序(NGS)技术的临床应用进行了探讨,旨在为西班牙制定临床实践建议,以确保将这些技术统一应用于产前护理。
成立了一个由产科医生和遗传学家组成的联合委员会,对胎儿 NGS 进行遗传诊断的现有文献进行了回顾,并为西班牙医疗保健专业人员提出了建议。
本指南总结了 NGS 技术的技术方面、产前适应证、应报告结果的考虑因素、遗传咨询考虑因素以及数据存储和保护政策。
本文为产前诊断中 NGS 诊断测试的使用提供了最新建议。随着我们对 NGS 技术在怀孕期间的临床应用的认识不断提高,这些建议应定期进行审查。